Appia Begins Extensive Auger and Reverse Circulation Drilling Campaign at Its Ionic Clay PCH Project, Brazil
TORONTO, ON, Jul 18, 2023 – (ACN Newswire) – Appia Rare Earths & Uranium Corp….
Month: July 2023
AI and Big Data Expo Europe Announces New Speakers
Amsterdam, July 18, 2023 – (ACN Newswire) – Leaders from across the tech industry will…
Appia Begins Extensive Auger and Reverse Circulation Drilling Campaign at Its Ionic Clay PCH Project, Brazil
Toronto, Ontario–(ACN Newswire – July 18, 2023) – Appia Rare Earths & Uranium Corp. (CSE:…
Socure Partners with MeridianLink to Enhance the Account Opening Process for Credit Unions, Banks, and Fintechs Providing Industry-leading Accuracy in Identity Verification and Fraud Capture
INCLINE VILLAGE, Nev.–(BUSINESS WIRE)–Socure, the leading provider of digital identity verification and fraud solutions, announced…
Qumulo Broadens Availability of Azure Native Qumulo to New Regions Across Europe, North America and the United Kingdom
Companies in these regions able to provision fully managed, enterprise-scale file system in the cloud…
Report Finds 78% of Financial Services Organizations Have Experienced a Cybersecurity Breach, Threat and Data Theft
Global research demonstrates the financial services industry has been hardest hit by cloud data security…
Helios Technologies Announces Retirement of Chief Financial Officer Tricia L. Fulton and Names Sean P. Bagan as Successor
SARASOTA, Fla.–(BUSINESS WIRE)–Helios Technologies, Inc. (NYSE: HLIO) (“Helios” or the “Company”), a global leader in…
Ceapro Announces Next Phase of Research Collaboration with the Angiogenesis Foundation
– New studies to focus on speed of healing and molecular profiling of tissue regeneration…
Ceapro Announces Next Phase of Research Collaboration with the Angiogenesis Foundation
– New studies to focus on speed of healing and molecular profiling of tissue regeneration…
Celularity Human Placental-Derived Advanced Biomaterials Demonstrate Superior Biocompatibility and Better Support Differentiated Cell Functions in Studies
Celularity will present benchtop and clinical case studies suggesting the therapeutic potential of its human…
Celularity Human Placental-Derived Advanced Biomaterials Demonstrate Superior Biocompatibility and Better Support Differentiated Cell Functions in Studies
Celularity will present benchtop and clinical case studies suggesting the therapeutic potential of its human…
BioCorRx Submits Fast Track Application to FDA for BICX104, an Implantable Biodegradable Naltrexone Pellet for The Treatment of Opioid Use Disorder
ANAHEIM, CA, July 18, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – BioCorRx Inc. (OTCQB: BICX)…
BioCorRx Submits Fast Track Application to FDA for BICX104, an Implantable Biodegradable Naltrexone Pellet for The Treatment of Opioid Use Disorder
ANAHEIM, CA, July 18, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – BioCorRx Inc. (OTCQB: BICX)…
Shockwave Medical Announces Details for Conference Call Discussing Second Quarter 2023 Results and Participation in Upcoming Investor Conference
SANTA CLARA, Calif., July 18, 2023 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a…
Shockwave Medical Announces Details for Conference Call Discussing Second Quarter 2023 Results and Participation in Upcoming Investor Conference
SANTA CLARA, Calif., July 18, 2023 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a…
Revolo Biotherapeutics Announces Additional Data from Phase 2a Trial of ‘1104 in Adults with Active Eosinophilic Esophagitis
– Data shows statistically significant improvement in patient-reported dysphagia symptoms compared to placebo – –…
Revolo Biotherapeutics Announces Additional Data from Phase 2a Trial of ‘1104 in Adults with Active Eosinophilic Esophagitis
– Data shows statistically significant improvement in patient-reported dysphagia symptoms compared to placebo – –…
electroCore Expands Intellectual Patent Portfolio for nVNS Technology
ROCKAWAY, N.J., July 18, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic…
electroCore Expands Intellectual Patent Portfolio for nVNS Technology
ROCKAWAY, N.J., July 18, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic…
Grifols Completes Enrollment in Phase 3 Study of Long-term Albutein® (albumin-human injection) Therapy for Patients with Decompensated Cirrhosis
PRECIOSA clinical trial is designed to evaluate efficacy and safety of Grifols Albutein® plus standard…